chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning her 77 year old mother with a arthritis in her finger, osteopenia and no known drug allergies who in December 2006 was vaccinated SC with a 0.5 ml dose of Zostavax vaccine. Concomitant therapy included Celebrex, alendronate sodium and calcium (unspecified). Subsequently four to six days after vaccination, in December 2006, the patient developed sciatica. She was treated with oral steroids. As of 25-Jan-2007 the patient was recovering. The physician reported that her mother was still having some problems and was going to physical therapy. She explained that prior to vaccination, her mother was very healthy and active and exercised on a regular basis. It was noted that the patient had no rash. The physician considered the sciatica to be disabling and an other important medical event. Additional information has been requested.
Received Janssen vaccine on 7/22/21 Tested positive for COVID by PCR on 11/1/21 admitted to HOSPTIAL on 11/2/21 d/t SOB, fatigue, weakness
Developed Insomnia and Excessive Daytime Sleepiness at the end of March 2014. Developed Cataplexy symptoms April 2014. Diagnosed Narcolepsy with Cataplexy June 5th 2014.
Had flu like symptoms; headaches; chills; body aches.; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Had flu like symptoms), HEADACHE (headaches), CHILLS (chills) and MYALGIA (body aches.) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Had flu like symptoms), HEADACHE (headaches), CHILLS (chills) and MYALGIA (body aches.). At the time of the report, INFLUENZA LIKE ILLNESS (Had flu like symptoms), HEADACHE (headaches), CHILLS (chills) and MYALGIA (body aches.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-085226 (Patient Link).
Agitation, Dizziness, Anaphylaxis, Angioedema, Diarrhea, Palpitations & Tachycardia Narrative:  Initially presented for Moderna COVID vaccine on 12/30/2020 and was advised by two nurses to wait 2 weeks before receiving the Moderna vaccine because he had received a live virus vaccine (MMR) on 12/24/2020. The patient left the vaccine area, but returned the next day, 12/31/2020, and repeated the screening process with different staff members; he neglected to inform them that he had been advised to wait 2 weeks to receive the shot, not did he inform them that he had received a live virus vaccine the prior week.
Dont know if related or not-- around vaccine date noticed I was "dribbling" when drinking out of water bottle about 4-20-21-, mentioned to Doctor have been dribbling last week or 2 - look at me- told me right side of mouth not moving- thought I had stroke and told to go to e.r where they confirmed there was a stroke and I also had 30 % blockage in right carotid artery.  Could also be related to ADD med( Vyvanse have been taking for last 10 years)- as med causes spike- high blood pressure.
pt recvd vax; states cold ever since shot; yellow rhinorrhea x 1 mo;tx w/ atb;
nonproductive cough, nasal congestion, swollen glands, sneezing, itchy eyes. starting 1/16/2022
30 hours of flu like symptoms, severe body aches, chills, and 100.5 f fever.  Day flu symptoms resolved, mild - moderate episodic daily left sided sharp chest pain for over 6 weeks, present most waking hours. Resolved but then returned with break through COVID infection 10 weeks post vaccination for another 6 weeks daily. Better but still intermittent several times weekly. Worse with physical exercise and I am normally very fit
About 5 minutes after receiving the vaccine, he reports that he began feeling dizzy and hot, he was assisted to bed in observation and vital signs checked - within normal limits. After about 2-3 minutes he began feeling better, appeared with color normal for ethnicity. Offered water, rest. Observed for 30 minutes without incident and improved symptoms. EMS offered, declined. Assisted to car in wheelchair and driven home by family member
This spontaneous report as received from a pharmacist refers to a 42 year old female patient. The patient's pertinent medical history included respiratory lung disease. The patient's drug allergies were none. On 08-OCT-2014 the patient was vaccinated with expired dose of PNEUMOVAX 23 (Dose/Frequency: 0.5 ml, lot # H022172 and expiry date: 16-AUG-2014) intramuscular in the left arm. Concomitant medications were none. On the same day (08-OCT-2014), the patient was administered FLUVIRIN in the left arm. On an unspecified date in 2014, the patient experienced soreness and hotness at the left arm injections sites. No treatment was provided for the events. Patient did not sought medical attention. Lab diagnostic tests performed were none. The outcome of soreness and hotness at the left arm injections sites was unknown. The causality of soreness and hotness at the left arm injection sites was unknown. Additional information has been requested.
On day of injection (Wed), itching of site of injection. By day after, redness on enter upper arm and continued itching. Chills, sweats, and headache began on Thursday afternoon  as well. Diarrhea started on Friday. Alternating chills, sweats, and headache continued through Wednesday, Jan 6th. Saw a provider on Monday, Jan 4th. Labs drawn on Wednesday, Jan 6th. Those resulted on Thurs, Jan 7th with no abnormalities. Saw provider again on Friday and by this day symptoms have subsided for the most part. Occasional sweats still occurring but able to resume ADL and return to work. Was out of work for 8 days.
Received Postive Covid-19 test results.  Admission to Hospital for diagnosis that included cough, shortness of breath, pneumonia.  Per notification, patient has not been admitted to an intensive care unit and has not required any mechanical ventilation during hospitalization to date.  It is unknown if he has been discharged from the hospital at this time.
Patient got 2nd shot 12 days after the 1st dose. 1st dose was given 05/20/2021, 2nd dose was given 06/01/2021. He had typical second dose adverse effects such as fever, chills, fatigue that lasted 24-48 hours.
This spontaneous prospective pregnancy report was received from a nurse practitioner, and refers to a 37 year old female patient. The patient's concurrent conditions included hypothyroidism. Medical history included abortion spontaneous (reported as "miscarriages"). Concomitant medications included levothyroxine 25 micrograms (mcg).The patient had no allergies or drug reactions. On 04-OCT-2017, the patient was vaccinated with a dose of VARIVAX for prophylaxis (route of administration, lot number and expiration date were not provided) and it was diluted with sterile diluent (manufacturer unknown). On 20-NOV-2017, the patient found out that she was pregnant because she did a home pregnancy test, and the result was positive; therefore she went to the physician's office. Her last menstrual period was reported as 11-OCT-2017. The estimated date of delivery was 18-JUL-2018. The trimester of exposure was 1 and the gestation period was 5 weeks. The pregnancy outcome was pending. The patient was referred to an obstetrician/gynecologist physician. The patient also reported having bilateral flank pain, a urine culture was done and the result was consistent with urinary tract infection (UTI). The patient did not received treatment for the event and there was no intervention to prevent a serious criteria. At the time of this report, it was unknown if the patient recovered from the event urinary tract infection. The reporter did not assess the causal relationship between therapy with VARIVAX, sterile diluent (manufacturer unknown) and the event.
Rash along neck, shoulders, all of the back, chest and torso.  what appears to be morbilliform rash not located on hands/feet or face. Ears are red as well, cannot tell if it is a reach
Child developed vomiting on 4/20/08 and was evaluated at hospital. An UGI showed intussusception. It was easily reduced with a Hypaque enema.  5/02/2008 MR received for ER visit 4/20/2008 with DX: Intussusception. Infant presented vomiting, refusal to eat, increased sleeping.  Bilious green emesis in ER. IS noted on UGI and BE. Successfully reduced.  7/31/09 Hospital records received DOS 7/2/09 to 7/9/09. First Admission 7/2/09 to 7/4/09. Assessment: Recurrent intussusception.  Patient presented with vomiting. Reduction of intussusception by enema. Second Admission 7/5/09 to 7/9/09. Discharged Diagnosis: Recurrent intussusception status post ileocolic resection and ileotransverse colon renanastomosis. After several previous reductions of intussusception by enema. Patient presented with increased fussiness, gastric emesis, bilious emesis. Decreased appetite. Bloody stool. Palpable epigastric mass. Enema reduction unsuccessful. Exploratory laparotomy with ileocolic resection and ileotransverse colon renanastomosis. Appendectomy. Ileum was quite edematous and lymph nodes in the ileocolic mesentary were massive.
Patient given 0.5 dose of influenza vaccine instead of ordered PREVNAR. Patient has already received both doses of flu vaccine this season.
no adverse effects; 1 patient was administered a dose of improperly stored PROQUAD; This spontaneous report was received from a medical assistant and refers to a 4-year-old patient of unknown gender. No information regarding the patient's pertinent medical history, concomitant medications and drug reactions or allergies was provided.  On 18-JUN-2019, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (Oka-Merck) virus vaccine live(PROQUAD) (lot # S005879 has been verified to be a valid lot number, expiration date was reported as 25-AUG-2020, but upon internal validation established as 18-JUN-2020) (therapy type rHA; dose, route of administration and anatomical location were not provided) for prophylaxis. The vaccine was reconstituted with a properly stored sterile diluent (lot # N035974 and expiry date 25-AUG-2020). Administered dose of vaccine experienced the temperature excursion 78 degrees Fahrenheit or warmer (79 degrees Fahrenheit) for 60 hours. There were no previous excursions reported. The data logger was not involved. There were no adverse effects reported.
Headache 24 hours from onset Body aches 24 hours from onset Fever 100:2 24 hours from onset Chills sporadic 24 hours from onset Fatigue 36 hours from onset
mom states pt felt hot, would not respond to verbal stimuli, when picked up eyes rolled up on head then stared ahead-took to ER;T105 & drooled alot;21MAY still has temp 104.3;lt ear infect, diarrhea, sz, viral;pharyngitis;
pt recvd vax & 2mins later pts lower extremities red, hot some swelling & mottled appearance; DPH ordered; sx resolved;
This case was reported by a consumer via call center representative and described the occurrence of itchy rash in a 67-year-old female patient who received Shingrix for prophylaxis. On 23rd May 2018, the patient received the 1st dose of Shingrix 50 µg. On an unknown date, less than a year after receiving Shingrix, the patient experienced itchy rash and scab. On an unknown date, the outcome of the itchy rash was recovered/resolved and the outcome of the scab was unknown. It was unknown if the reporter considered the itchy rash and scab to be related to Shingrix. Additional details were reported as follows: This case was reported via click to chat. The patient received Shingrix vaccine about 6 months before from the date of reporting. The patient had several individual small intensely itchy bumps, which started sometime in the summer of 2018, on trunk to shoulder, stomach and might be on back approximately 8 to 10 total, one at a time. They look like small insect bites and lasted for 2 to 3 days. The patient stated, bumps appeared one at a time and spread out more than she thought of a rash. After a few days, it dried up and with a minute scab. The patient asked could this be a side effect.
Fussy-red area on anterior aspect right thigh, no fever local reaction to vaccine. Observe-TYLENOL as needed for discomfort.
Pt recv vax on 11/4/98; 5 hr post vax pt exp right shoulder, knees, left hip &foot pain,pain walking, unable to move right shoulder, unable to sleep; dx=immune complex; tx=Theraflu, Prednisone, Naprosyn/Celebrex,ice, physical therapy
Patient was given influenza preservative free 3 years and older on 9-27-17, lot #U5896DA, instead of the influenza 6-35 mths. Lead staff notified as of 10:45AM. Lead staff notified the health dept. Lead staff advised to call the parent of the patient. Called and left message for mom at 2:29 PM to return my phone call. Mom returned my phone call @ 3:15PM I asked how the patient was doing? Mom stated that patient is doing "AMAZING". She has been her normal self ever since her shots yesterday. Mom rubbed her legs down with baby oil last night, she had a little lump. She wasn't fussy or whining at all. She slept ALL night. I then explained to mom of that the patient received the Influenza 0.5ml preservative free (age 3 years and older) and she would have received the Influenza 6-35 mths, 0.25ml  In two separate doses. I verbalized to the mom that I was SO SORRY, and I am very upset about this situation. I explained to her that I take my job and patients very seriously. She said that she understood. I advised patient's mom per individual from the county health dept stated: said the child/parent may notice increased redness/swelling/tenderness at injection site. There should not be any other concerns. The vaccine will not be repeated or replaced for patient. The individual will do her magic in the database so that it shows child is not due for a 2nd dose. Mom did state she was a little upset but nothing she can do about it now. Mom said she is running around playing and doing all of her normal routine. Mom stated that she wouldn't have know that, anything was wrong if I hadn't called. She did appreciate me calling to let her know of the situation. She is going to let her husband know. Her last comment to me was that she still wanted me to give her daughter her next set of shots. I apologized again. I finished the call with mom at 3:26PM.
I ran a fever and got sick after receiving the vaccine. I had a telehealth visit with my primary care doctor. My long COVID-19 symptoms got worse. I tested positive for COVID-19 in 03/2020. I got really sick with COVID-19 and almost had to be hospitalized. I had all the classic symptoms from the original version of COVID-19. I do special physical therapy, diet changes and breathing treatment to help me with my symptoms.
Received the shot Tuesday night on left arm. Soreness and pain for a day or two. Pain went away for a couple of days.  Saturday night started to get neck arm and shoulder sorness arm tingling and numbness and pain near elbow top of forearm. MD check injection site and no redness or tenderness at location of shot just arm and neck and back.  Was given steroid pack and muscle relaxer. Steroid pack made me feel worst and sick. Pain in arm comes and goes and neck. MD diagnosed possible pinch nerve.
This case was reported by a nurse via call center representative and described the occurrence of injection site pain in a 76-year-old male patient who received SHINGRIX for prophylaxis. On 3rd September 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was recovering/resolving. It was unknown if the reporter considered the injection site pain to be related to SHINGRIX. Additional details were reported as follows: The reporter reported that her husband had SHINGRIX dose and the patient was still complaining pain at the injection site.
4/21/2023   I was having coughing spells to the point when I took my medicine, I threw it all up , including my meal I had just eaten.  I also had diarrhea. The next morning, I had a low-grade fever and was coughing. I was freezing, shaking and could not get warm. I still had diarrhea. I had sinus congestion.   I could not keep water down. I had the worst headache and stayed in bed most of that day. 4/23/2023, I continued having the same symptoms, felt bad and stayed in bed all day.   I could not keep anything down, including water. On 4/24/23, my headache was finally let up so I could get out of bed for two hours. After that I was wiped out and went back to bed.  I had diarrhea and had no hunger. I took an at home COVID test which was positive. I called my doctor?s office. I was prescribed Paxlovid and began taking it on 4/26/23.  I am still congested, still coughing and have a faint headache. I am actually out of bed and able to barely function. I am very chilled and have trouble getting warm.  I lost my sense of taste and my sense of smell is diminished.
Menstruation delayed two weeks after first dose.  Arm rash itchy and painful to the touch, five inches across and joint pain, headache after second vaccine dose.
This patient states her left arm became very red and swollen after the vaccine. Her arm remained like that for a day. She states she was in a car accident and in the ER showed the doctors her arm. The doctors said they didn't think it was anything. They told her to see her private MD. She said she had not reported it to anyone else until now. She complained of not being able to lift her arm, sharp pain remains.
Information was received from a nurse practitioner referring to an unspecified patient. The patient's concurrent condition, medical history and concomitant therapy were not reported. On 10-JUL-2017, the patient was vaccinated with the first dose of GARDASIL 9 (dose, route, lot# and expiration date unknown) for prophylaxis. On 30-SEP-2017, the patient vaccinated with the second dose of GARDASIL 9. On 28-DEC-2017, the patient vaccinated with the third dose of GARDASIL 9 (Inappropriate schedule of drug administration). No adverse effects were reported. Follow up information has been received from the nurse practitioner (NP) on 11-JUL-2018. The NP reported the patient received the third dose of GARDASIL 9 eleven days too early. The GARDASIL 9 also reported she planned to revaccinate the patient with a fourth dose of GARDASIL 9. No adverse effects were reported. No additional information provided.
Given 1 ml of vaccine instead of 0.5ml; A spontaneous report was received from a pharmacist concerning a 33-year old, male patient who received Moderna's COVID-19 Vaccine and was given Moderna's vaccine 1ml instead of 0.5ml.  The patient's medical history was not provided. Concomitant product use was not provided by the reporter.  The patient received their first of two planned doses of mRNA-1273 (Batch number: 016M20A) on 09 Feb 2021, intramuscularly in left arm for the prophylaxis of COVID-19 infection.  On 09 Feb 2021, the patient received 1ml of the vaccine instead of 0.5ml. Treatment information was not provided.  Action taken with mRNA-1273 in response to the event was not reported.  The outcome of the event, given Moderna's vaccine 1ml instead of 0.5ml, was considered resolved on 09 Feb 2021.; Reporter's Comments: This reports refers to a case of Accidental overdose for mRNA-1273 (Batch number: 016M20A) with no associated AEs.
patient called 05/26 , expressing swollen areas by the armpit area , with discomfort  and pain . in both arms , left and right , asked the patient about the site of injection if it's painful or swollen more , he answered , no , confirming that the swollen was on both sides  under arms , nothing was observed about the site of administration( left deltoid) .    asked the patient if there are any other symptoms , or reaction elsewhere . he answered ,no, asked if there are any fever or pain in the extremities . he answered ,no, . advised the patient to get some rest and OTC pain relief meds if necessary ,.and will follow up the next day  on 05/27 , the patient was contacted , to follow up on the symptoms , patient confirmed that he still has the same symptoms , and wasn't getting better . so i advised the patient to reach out and contact his primary care physician or go to ER to be physically examined by a doctor . patient   agreed and informed him to contact us for a follow up
Covid-19; Covid-19; This is a solicited report received from contactable reporter(s) (Consumer or other non HCP) for a sponsored program. The reporter is the patient. Other Case identifier(s): 22K-163-4293116-00.  A 67 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administration date 27Feb2021 (Batch/Lot number: unknown) at the age of 66 years as dose 2, single and intramuscular, administration date 06Feb2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation; adalimumab (HUMIRA), subcutaneous (Batch/Lot number: unknown) for psoriatic arthropathy. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: COVID-19 (hospitalization, medically significant), VACCINATION FAILURE (hospitalization, medically significant) all with onset Aug2021, outcome "unknown" and all described as "Covid-19". The patient was hospitalized for covid-19, vaccination failure (hospitalization duration: 1 day(s)). The patient underwent the following laboratory tests and procedures: covid-19: (Aug2021) positive. The action taken for adalimumab was unknown. Causality for Humira(Adalimumab): The reporter's causality for the event of covid was not provided. Causality for BNT162B2: The reporter's causality for the event of covid was not provided. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Based on the information in the case report, contributory role of BNT162B2 to the development of vaccination failure, Covid-19 cannot be ruled out.
Returned to office 6 hours after immunization with redness at site of PENTACEL and fussiness. Exam significant for 16 cm x 10 cm of erythema centered at anterior medial right thigh, no induration palpated. Rest of exam normal. Redness resolved in a couple hours - slight fussiness the rest of the evening.
Mom described non-stop high pitched crying lasting over two hours after immunizations on 7/17/06.Mom stated crying started approximately two hours after immunizations were given. Also states very unusual behaviour for her child.  Mom described non-stop crying after first set on 3/24/06 but not as long of duration.
Patient is a 66 y.o. female with an unknown PMHx admitted with DKA and found to have thrombocytopenia, an intraparenchymal bleed on Head CT 2/2 to dural venous thrombosis. Course also complicated by saddle submassive PE w/ + biomarkers and mild RHS.  Given unclear etiology of thrombocytopenia, venous thrombosis, and PE, suspect a precipitating/underlying etiology and cannot rule out possible occult malignancy, autoimmune disorder or alternative hypercoagulable state such as APLS. Possibly bacteremic given GPB and Staph on blood cx, though likely contaminant. DKA resolved, anion gap is closed, continued monitoring of glucose and insulin adjustment .OB/Gyn following for heavy vaginal bleeding and possibly gyn malignancy workup, endometrial biopsy pending. Heme also following.
Moderna vaccine was administered outside of source - reported by patient ? NO LOT NUMBER WERE SUPPLIED  I95.9 HYPOTENSION 1/24/2022 ABDOMINAL PAIN I95.9 HYPOTENSION 1/24/2022 CANCER METASTATIC TO LIVER I95.9 HYPOTENSION 1/24/2022 CANCER METASTATIC TO LIVER I95.9 HYPOTENSION 1/24/2022 JAUNDICE I95.9 HYPOTENSION 1/24/2022 CANCER METASTATIC TO LIVER
No adverse event, administration error.  Patient was given the Men. A conjugate with a sterile diluent instead of the Men. CYW conjugate.  Per CDC, dose must be repeated with no minimum interval to ensure patient receives coverage for Men CYW.